News
Remaking Philadelphia at NextFab
From out of the rubble, something new emerges: Despite the decades-long decline of assembly-line, smokestack-style manufacturing in Philadelphia, there is new growth in small-scale makers and artisans. A key ingredient in that shift is the city’s incubators and makerspaces.
Read MoreMaking a Difference in 2018
Few women around the world can get a mammogram. They are far from a clinic, or lack the money, or just don’t know about breast cancer. But now there’s another kind of breast exam that could reach women that mammograms don’t.
Read MoreMeet Lia: At-Home Pregnancy Steps Into The 21st Century
As a professor who teaches entrepreneurship, I’m often asked if it can truly be taught. Unsurprisingly, my answer is yes. To back up that assertion, I’d like to share the story of a terrific company that came about because of a school assignment: Lia Diagnostics, co-founded by Bethany Edwards and Anna Simpson.
Read MoreFounders’ Story: VitalTrax
Zikria Syed is the CEO and co-founder of VitalTrax. He talks about why he and co-founder Todd Kueny started their business to make clinical trials more efficient.
Read MoreLia Diagnostics raises $2.6M for its flushable & biodegradable pregnancy test
Lia Diagnostics, the Philadelphia company that has developed a flushable and biodegradable home pregnancy test, raised $2.6 million in a private equity financing.
Read MoreDRIVe Awards InnaMed
The first Science Center-affiliated company has been awarded a contract through The Biomedical Advanced Research and Development Authority (BARDA) for research addressing health security threats.
Read MoreAUM LifeTech, CHOP and Penn Partnering to Advance Cancer Immunotherapy Against Lung Cancer Using Foxp3 Gene Silencing FANA ASO Therapy
AUM LifeTech, Inc., a Philadelphia-based biotech company, has partnered with the Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania to employ next-generation RNA silencing FANA technology as a new approach to cancer immunotherapy designed to treat lung cancer. The preclinical results were presented at the 2018 Annual Meeting of the Oligonucleotide Therapeutics Society (OTS) in Seattle, WA.
Read MorePitt awards $300,000 to healthcare startups improving human performance
LungHealth-E, Health-E-Nose and ThreadRite IV won the top prizes at this year's Pitt Innovation Challenge
Read MoreIntegral Molecular Partners with Merus to Discover Novel Therapeutic Monoclonal Antibodies
Integral Molecular, the industry leader in the discovery of monoclonal antibodies (MAbs) against membrane proteins, and Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that they have entered into a collaboration on multiple undisclosed targets.
Read MoreStartup SocialLadder's new deal with Ticketmaster division is a 'big win'
Philadelphia tech startup SocialLadder is moving up another rung, announcing Monday the company, which connects live event promoters with more than 150,000 brand ambassadors to drive ticket sales, landed a major deal with a division of Live Nation’s Ticketmaster.
Read More